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a  b  s  t  r  a  c  t
Doxorubicin  is  a chemotherapy  drug but  its  clinical  using  is  limited  because  of its cardiotoxicity.  Reac-
tive  oxygen  species  play  an  important  role  in  the pathological  process.  The  aim  of this  study  is  to  evaluate
the  protective  effect  of  Rheum  turkestanicum  Janisch.,  Polygonaceae,  against  doxorubicin-induced  apo-
ptosis and  death  in  H9c2  cells.  The  cells  were  incubated  with  different  concentrations  of R.  turkestanicum
extract  and  N-acetylcysteine  as positive  control  for 2 h,  followed  by  incubation  with  5 M  doxorubicin
for  24  h. Cell  viability  and  apoptotic  induction  were  determined  by using  MTT  and  PI  assays,  respectively.
The  level  of  reactive  oxygen  species  and  lipid peroxidation  was measured  by ﬂuorimetric  methods.  Doxo-
rubicin  signiﬁcantly  decreased  cell  viability  which  was  accompanied  by  an  increase  in  ROS  production
and  lipid  peroxidation.  Pretreatment  with  R.  turkestanicum  increased  the  viability  of cardiomyocytes  and
could  decrease  lipid peroxidation  and  reactive  oxygen  species  generation.  Also,  R.  turkestanicum  atten-
uated  apoptotic  induction.  N-acetylcysteine  at 100  M reduced  the  levels  of  reactive  oxygen  species
and  lipid  peroxidation.  But,  treating  H9c2  cells  with  N-acetylcysteine  did  little  to protect  H9c2  cells  from
doxorubicin-induced  cell  death.  R.  turkestanicum  exerts  protective  effect  against  oxidative  stress-induced
cardiomyocytes  damage.  Our  ﬁndings  showed  that R.  turkestanicum  could  exert  the cardioprotective
effects  against  doxorubicin-induced  toxicity  partly  by anti-apoptotic  activity.  Also,  N-acetylcysteine  pre-
vented  oxidative  stress  via  reduction  of  reactive  oxygen  species  and  lipid  peroxidation.  N-acetylcysteine
induced  less  protective  effects  than  R. turkestanicum  extract  against  doxorubicin-induced  cytotoxicity.
© 2016  Sociedade  Brasileira  de Farmacognosia.  Published  by Elsevier  Editora  Ltda.  This  is  an open
he  CCaccess  article  under  t
ntroduction
Doxorubicin (DOX) as an effective chemotherapy drug has seri-
us side effects such as dilated cardiomyopathy and congestive
eart failure (Turakhia et al., 2007). Therefore, using this drug must
e limited. The mechanisms of DOX-induced cardiotoxicity are not
ompletely understood, but most evidences indicate that the gen-
ration of reactive oxygen species (ROS) is involved (Bryant et al.,
007). Increased level of ROS leads to protein and lipid peroxida-
ion, DNA damage and irreversible cell damage (Ghorbani et al.,
015; Asadpour et al., 2014). ROS can directly impair contrac-
ile function, activate hypertrophy signaling pathways, stimulate
ardiac ﬁbroblast proliferation and induce extracellular matrix
emodeling (Takimoto and Kass, 2007; Tsutsui et al., 2011). Exces-
ive ROS also cause accumulation of intracellular Ca2+ in cardiac
ells which increases the mitochondrial permeability and leads to
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the release of cytochrome c into the cytoplasm and the following
apoptotic cascades (Pacher et al., 2001). Interestingly, some nat-
ural foods have been reported to contain substantial amounts of
antioxidants and free radical scavenging agents. These compounds
diminish some side effects of chemotherapeutic agents on nor-
mal  cells by reducing their genotoxicity (Bryant et al., 2007). H9c2
myoblasts, a rat embryonic cell line, which has the ability to dif-
ferentiate between a skeletal or cardiac muscle phenotype, can
be instrumental in understanding DOX cytotoxicity in different
stages (Branco et al., 2012). The recent studies have shown that
some of the herbs act against oxidative injury-related cardiotoxic-
ity. Rheum species, Polygonaceae, have a long history as medicinal
plants in traditional Chinese medicine. The main active ingredients
of the Rheum species are a series of anthraquinones, dianthrones,
glycosides and tannins. The anthraquinone derivatives include
emodin, rhein, chrysophanol, physcion, alizarin, citreorosein, and
aloe-emodin (Dorsey and Kao, 2007). R. turkestanicum Janisch. is a
plant that grows widely in central Asia and also in northeast of Iran.
Traditionally, people use roots of R. turkestanicum as an anti-
diabetic and anti-hypertensive as well as anticancer agent
ditora Ltda. This is an open access article under the CC BY-NC-ND license
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Dorsey and Kao, 2007). Recent studies have shown other species of
heum such as R. undulatum is containing anti-oxidant compounds.
hapontigenin and rhaponticin are isolated from R. undulatum
cavenge ROS, the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical,
nd hydrogen peroxide (H2O2) (Zhang et al., 2007). Also, these com-
ounds decrease membrane lipid peroxidation and cellular DNA
amage, which are the main targets of oxidative stress-induced cel-
ular damage (Zhang et al., 2007). The recent study showed some
f isolated anti-oxidant compounds from Rheum species such as
. emodi protected H9c2 cells against H2O2 (Chai et al., 2012).
n this study, the protective effect of hydro-alcoholic extract of
. turkestanicum on DOX-induced cardiotoxicity was  evaluated for
rst time.
aterial and methods
eagents
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium (MTT),
hiobarbituric acid (TBA), 2,7-dichloroﬂuorescin diacetate (DCFH-
A), propidium iodide (PI), N-acetylcysteine (NAC), sodium citrate
nd Triton X-100 were purchased from Sigma (St. Louis, MO,
SA). High-glucose Dulbecco’s Modiﬁed Eagles Medium (DMEM),
enicillin-streptomycin and fetal bovine serum were purchased
rom Gibco. Trichloro acetic acid (TCA) and malondialdehyde bis-
dimethyl acetal) (MDA) were obtained from Merck (Darmstadt,
ermany).
reparation of extracts
The root of Rheum turkestanicum Janisch., Polygonaceae, was
ollected from Chenar, a village in Zavin Rural District, Kalat
ounty, Razavi Khorasan Province, Iran. The plant was  identiﬁed
y M.R. Joharchi, from Ferdowsi University of Mashhad Herbarium.
oucher specimen (No. 21377) was deposited in Ferdowsi Univer-
ity of Mashhad Herbarium. Dried R. turkestanicum root (20 g × 3)
as ground into ﬁne powder and then 50 g of this powder was
ubjected to extraction with 70% ethanol in a Soxhlet apparatus for
8 h. The hydro-alcoholic extract was then dried on a water bath
nd kept frozen in less than −18 ◦C for the following use. The yield
f extract was 19% (w/w). The extract was dissolved in dimethyl-
ulfoxide (DMSO) to a ﬁnal concentration of 50 mg/ml  before being
sed in cytotoxicity and apoptosis assays.
ell culture
Rat heart cell line H9c2 was obtained from American Type
ulture Collection (ATCC CRL-1446) and maintained at 37 ◦C in
 humidiﬁed atmosphere containing 5% CO2. The cells were cul-
ured in DMEM supplemented with 10% fetal bovine serum and
00 units/ml penicillin and 100 g/ml streptomycin. For the exper-
ments, they were seeded in 96-well and 24-well culture plates
or MTT/ROS and MDA  assays, respectively. For apoptosis assay,
ells were seeded at 100,000/well in a 24-well plate. All treatments
ere carried out in triplicate. The cells were pretreated with extract
6–200 g/ml) for 2 h and then incubation was continued in the
resence of the extract with 5 M doxorubicin for 24 h. Also, NAC
as applied as positive control at 10 and 100 M.
ell viabilityThe cell viability was determined using a modiﬁed 3-(4,5-
imethylthiazol-2-yl)-2,5-diphenyl tetrazolium (MTT) assay as
escribed previously (Mosmann, 1983; Malich et al., 1997). Brieﬂy,
TT solution in phosphate-buffered saline (5 mg/ml), was addede Farmacognosia 26 (2016) 347–351
to each well at ﬁnal concentration of 0.05%. After 3 h, the form-
azan precipitate was dissolved in DMSO. The absorbance at 570
and 620 nm (background) was measured using a StatFAX303 plate
reader. The experiment was  carried out in triplicate.
Lipid peroxidation assay
The level of lipid peroxidation was estimated by measuring MDA
which is the end product of lipid peroxidation. At the end of incu-
bation, the cells were scraped and centrifuged at 13,000 × g at 4 ◦C
for 30 min  (Buege and Aust, 1978). Then, 400 l of TCA (15%) and
800 l of TBA (0.7%) were added to 500 l of cell samples. The mix-
ture was  vortexed and then heated for 40 min  in a boiling water
bath. Then, 200 l of the sample was  transferred to 96-well plate
and the ﬂuorescence intensity was  read with excitation/emission
of 480/530 nm. The experiment was carried out in triplicate.
Measurement of reactive oxygen species
Intracellular ROS level was  evaluated using a ﬂuorescent probe,
DCF-DA (Wu and Yotnda, 2011). At the end of incubation, the
cells were treated (30 min) with DCFH-DA (10 M)  at 4 ◦C in the
dark. Then, the ﬂuorescence intensity was detected with excita-
tion/emission of 485/530 nm.  The experiment was performed in
triplicate.
Apoptosis
Apoptotic cells were detected by using PI staining of the treated
cells followed by ﬂow cytometry to detect the so-called sub-G1
peak. Brieﬂy, H9c2 cells were cultured overnight in a 24-well plate
and pretreated by R. turkestanicum for 4 h and then treated with
DOX for 24 h. Floating and adherent cells were then harvested and
incubated at 4 ◦C overnight in the dark with 500 l of a hypotonic
buffer (50 g/ml PI in 0.1% sodium citrate plus 0.1% Triton X-100).
The experiment was  carried out in triplicate (Nicoletti et al., 1991).
Statistics
All data were expressed as mean ± SEM. Statistical analysis was
performed using one way analysis of variance (ANOVA) followed by
Tamhane’s T2 post hoc test. Differences were considered signiﬁcant
at p < 0.05.
Results
Effect of DOX on cell viability
Incubation of the cells with different concentrations of DOX
(2.5–20 M)  showed that the cell viability reduced in a dose
dependent manner (Fig. 1).
Effect of R. turkestanicum extract on cell viability
Incubation with 6 M DOX signiﬁcantly decreased cell viability
to 55 ± 4.5% of control (p < 0.001). Pretreatment with 12–200 g/ml
of R. turkestanicum could increase the viability of H9c2 cells to
71 ± 0.68% (p < 0.05), 74.6 ± 2.5% (p < 0.01), 79 ± 1.3% (p < 0.001),
84 ± 3.6% (p < 0.001) and 88 ± 1.3% (p < 0.001) of control, respec-
tively (Fig. 2). However, at dose of 6 g/ml, R. turkestanicum was
not able to protect H9c2 cells against DOX-induced cytotoxicity.
Also pretreatment of cells with NAC at doses of 10 and 100 M,
protected cells against DOX (5 M)  at dose of 100 M (69 ± 1.8%,
p < 0.05) (Fig. 2).
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Fig. 1. Dose–response curve of DOX on viability of H9c2 cells. The cells were treated
with different concentrations (2.5–20 M)  of DOX for 24 h. The cell viability was
quantitated by MTT assay. Results are mean ± SEM from three independent experi-
ments. ***p < 0.001, *p < 0.05 versus control.
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Fig. 2. Effect of Rheum turkestanicum extract and NAC (positive control) on via-
bility of H9c2 cells. The cells were pretreated with different concentrations
(25–200 g/ml) of the extract for 2 h, then exposed to doxorubicin (DOX) for 24 h.
The cell viability was  quantitated by MTT  assay. Results are mean ± SEM from
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Fig. 3. The effects of Rheum turkestanicum extract and NAC (positive control) on
intracellular ROS level of under doxorubicin treatment in H9c2 cells. The cells were
pretreated with different concentrations (25–200 g/ml) of the extract for 2 h, then
exposed to doxorubicin (DOX) for 24 h. Results are mean ± SEM from three inde-
pendent experiments. ###p < 0.001 versus control, **p < 0.01 and ***p < 0.001 versus
DOX.
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Fig. 4. The effects of Rheum turkestanicum extract and NAC (positive control) on
MDA  content under doxorubicin treatment in H9c2 cells. The cells were pretreated
with different concentrations of the extract (25–200 g/ml) for 2 h, then exposed to
therapy for three decades. However, the clinical use of DOX  ishree independent experiments. ###p < 0.001 versus control, *p < 0.05, **p < 0.01 and
**p  < 0.001 versus DOX.
ffect of R. turkestanicum on ROS production
As expected, DOX caused a signiﬁcant increase in the level of
OS in H9c2 cells (217 ± 4.6% of control, p < 0.001). The extract
t concentrations of 25, 50, 100 and 200 g/ml was  able to
ecrease intracellular ROS level to 186 ± 5.2% (p < 0.01), 171 ± 4.6%
p < 0.001), 146 ± 1.1% (p < 0.001) and 132 ± 2.6% (p < 0.001) of con-
rol, respectively (Fig. 3). Also, NAC at dose of 100 M signiﬁcantly
ecreased ROS production (165 ± 2.3%, p < 0.001) (Fig. 3).
ffect of R. turkestanicum extract on MDA  level
The level of lipid peroxidation was evaluated by measuring
f MDA  level, which is the end product of lipid peroxidation.
s shown in Fig. 4, exposure of the cells to DOX resulted
n a signiﬁcant increase of MDA  level (168 ± 6.5%, p < 0.001)
s compared to control cells cultured in the absence of DOX
100 ± 1.3%). The content of MDA  was signiﬁcantly decreased
n the cells pretreated with 25 g/ml (137 ± 1.5%, p < 0.01),
0 g/ml (129 ± 2.1%, p < 0.001), 100 g/ml (117 ± 3.3%, p < 0.001),
r 200 g/ml (110 ± 4.1%, p < 0.001) of R. turkestanicum.  Also, NAC5  M doxorubicin and incubated for 24 h. Results are the means ± SEM from three
independent experiments. ###p < 0.001 versus control, **p < 0.01 and ***p < 0.001
versus DOX.
at dose of 100 M signiﬁcantly decreased MDA  content (120 ± 2.8%,
p < 0.001) (Fig. 4).
Effect of R. turkestanicum on apoptotic cell death
The proportion of apoptotic cells was  measured with PI staining
of DNA fragmentation by ﬂow cytometry. The extract induced a
sub-G1peak (one of the reliable biochemical markers of apoptosis)
in ﬂow cytometry histogram of treated cells compared to control
(Fig. 5).
Discussion
Our ﬁndings showed doxorubicin increased cell death, ROS
generation, MDA  production and induced apoptotic cell death.
R. turkestanicum decreased cytotoxic effects of doxorubicin in car-
diomyoblast cells. The extract increased cell viability, reduced
ROS and MDA  production. Also, NAC as positive control, pro-
tected the cells against DOX via reduction of ROS and MDA
levels.
DOX, as an anthracycline antibiotic, has been used in cancerlimited because of it increased risk of cardiotoxicity (Wencker et al.,
2003; Xin et al., 2009). In addition, DOX affect on speciﬁc enzymes,
transporters, and metabolic pathways in the cardiac muscle. The
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rom  three independent experiments. ###p < 0.001 versus control, **p  < 0.01 and ***
ccumulation of these defects may  ultimately result in irreversible
ardiac failure (Tokarska-Schlattner et al., 2006). The main mech-
nism of DOX-induced cardiotoxicity is production of ROS as a
erivative of the DOX metabolism (Liu et al., 2009; Zhang et al.,
009). However, superoxide radicals are involved in other ROS
nd generate hydroxyl radical and hydrogen peroxide (Bast et al.,
007). Cardiac tissue is sensitive to oxidative damage because of
ts high oxidative metabolism and low antioxidant defenses in this
rgan compared with others (Pinto et al., 1986; Shug, 1987). In the
resent study H9c2 cells were used as a pharmacological model to
valuate the potential cardioprotective effect of R. turkestanicum
gainst doxorubicin. The results showed that R. turkestanicum
as protective effect on H9c2 cells against DOX-induced oxida-
ive stress. H9c2 cells are morphologically similar to immature
mbryonic cardiomyocytes. Considering that these cells preserve
lectrical and hormonal signal pathways found in adult cardiac
ells (Sheng et al., 2010), they are a useful model for studying
xidative stress-induced cardiomyocyte damage (Winstead et al.,
005). In this model, DOX signiﬁcantly increased lipid peroxida-
ion and induced the apoptotic rate. These changes are similar to
he DOX-induced deleterious effects on normal cardiac cells which
ead to the loss of cardiomyocytes viability. According to current
eports, generating ROS by DOX causes mitochondrial damage,
hich may  lead to cardiomyocyte apoptosis, necrosis, or death.
he studies have shown, some natural substances, such as cur-
umin, naringenin-7-O-glucoside, and plantainoside D prevented
OX-induced mitochondrial injuries in cardiomyocytes (Kim et al.,
007; Hosseinzadeh et al., 2011). In our study, we used DCFH-DA as
n intracellular method of ROS detection. The results demonstrated
hat R. turkestanicum can signiﬁcantly reduce the intracellular ROS
roduction by DOX in H9c2 cells. We  also measured lipid per-
xidation (MDA formation) in H9c2 cells. The reduction of MDA
ontent suggested that R. turkestanicum can attenuate the oxida-
ive stress induced by DOX in H9c2 cells. Also results showed NAC
s potent anti-oxidant protected cells against DOX via reduction of
xidative-stress. The recent studies have shown NAC inhibited ROS
roduction, lipid peroxidation, and restored antioxidant enzyme
ctivities but had modest effect on the protection of DOX-inducednt in H9c2 cells using PI staining and ﬂow cytometry. Results are the means ± SEM
01 versus DOX.
cardiac cell death as compared to other natural sources of antiox-
idants (Shi et al., 2009). NAC induced less protective effects than
R. turkestanicum extract against DOX-induced cytotoxicity. How-
ever protective effects of extract may be mediated via mechanisms
similar to NAC.
Conclusion
This study shows that R. turkestanicum is a novel potent pro-
tective agent against DOX-induced cardiotoxicity, the protective
effects may  be due to its antioxidant properties. This effect is cor-
related with reducing oxidative stress and inhibition of apoptosis
induction. But more investigations are needed to elucidate the
probable underlying mechanisms of these therapeutic effects.
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